Skip to main content
All lobbying filings

THORNROSE VENTURES

Lobbying for MINO, LLC · Precision peptide medicine and healthcare technology company.

 Filing Registration
3rd Quarter (July 1 - Sep 30) 2026 · New Jersey · posted Jul 22, 2026

Official filing document

 Lobbying activity 5
Government Issues

Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.

Health Issues

Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.

Pharmacy

Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.

Medical/Disease Research/Clinical Labs

Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.

Science/Technology

Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem